EWTX logo

Edgewise Therapeutics, Inc. (EWTX) Operating profit

annual operating profit:

-$158.83M-$44.48M(-38.89%)
December 31, 2024

Summary

  • As of today (September 17, 2025), EWTX annual operating income is -$158.83 million, with the most recent change of -$44.48 million (-38.89%) on December 31, 2024.
  • During the last 3 years, EWTX annual operating profit has fallen by -$115.62 million (-267.54%).
  • EWTX annual operating profit is now -1500.48% below its all-time high of -$9.92 million, reached on December 31, 2019.

Performance

EWTX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXincome statement metrics

quarterly operating profit:

-$42.61M+$3.35M(+7.29%)
June 30, 2025

Summary

  • As of today (September 17, 2025), EWTX quarterly operating income is -$42.61 million, with the most recent change of +$3.35 million (+7.29%) on June 30, 2025.
  • Over the past year, EWTX quarterly operating profit has dropped by -$4.50 million (-11.82%).
  • EWTX quarterly operating profit is now -1211.88% below its all-time high of -$3.25 million, reached on March 31, 2020.

Performance

EWTX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXincome statement metrics

TTM operating profit:

-$174.54M-$4.50M(-2.65%)
June 30, 2025

Summary

  • As of today (September 17, 2025), EWTX TTM operating income is -$174.54 million, with the most recent change of -$4.50 million (-2.65%) on June 30, 2025.
  • Over the past year, EWTX TTM operating profit has dropped by -$38.37 million (-28.17%).
  • EWTX TTM operating profit is now -5273.80% below its all-time high of -$3.25 million, reached on March 31, 2020.

Performance

EWTX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

EWTX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-38.9%-11.8%-28.2%
3 y3 years-267.5%-158.4%-205.1%
5 y5 years-1500.5%-976.8%-2322.5%

EWTX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-267.5%at low-158.4%+7.3%-205.1%at low
5 y5-year-1500.5%at low-976.8%+7.3%-2322.5%at low
alltimeall time-1500.5%at low-1211.9%+7.3%-5273.8%at low

EWTX Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$42.61M(-7.3%)
-$174.54M(+2.6%)
Mar 2025
-
-$45.96M(+0.9%)
-$170.04M(+7.1%)
Dec 2024
-$158.83M(+38.9%)
-$45.54M(+12.6%)
-$158.83M(+7.9%)
Sep 2024
-
-$40.43M(+6.1%)
-$147.15M(+8.1%)
Jun 2024
-
-$38.11M(+9.7%)
-$136.17M(+10.3%)
Mar 2024
-
-$34.75M(+2.6%)
-$123.41M(+7.9%)
Dec 2023
-$114.36M(+59.6%)
-$33.86M(+15.0%)
-$114.36M(+11.5%)
Sep 2023
-
-$29.45M(+16.2%)
-$102.57M(+12.2%)
Jun 2023
-
-$25.34M(-1.4%)
-$91.38M(+10.7%)
Mar 2023
-
-$25.70M(+16.4%)
-$82.54M(+15.2%)
Dec 2022
-$71.66M
-$22.08M(+20.9%)
-$71.66M(+14.8%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$18.26M(+10.7%)
-$62.40M(+9.1%)
Jun 2022
-
-$16.49M(+11.2%)
-$57.22M(+11.8%)
Mar 2022
-
-$14.83M(+15.6%)
-$51.18M(+18.4%)
Dec 2021
-$43.22M(+151.4%)
-$12.82M(-1.9%)
-$43.22M(+17.6%)
Sep 2021
-
-$13.08M(+25.0%)
-$36.74M(+55.3%)
Jun 2021
-
-$10.46M(+52.5%)
-$23.66M(+37.9%)
Mar 2021
-
-$6.86M(+8.1%)
-$17.16M(+26.6%)
Dec 2020
-$17.19M(+73.2%)
-$6.34M(+60.3%)
-$13.55M(+88.0%)
Jun 2020
-
-$3.96M(+21.8%)
-$7.21M(+121.8%)
Mar 2020
-
-$3.25M
-$3.25M
Dec 2019
-$9.92M
-
-

FAQ

  • What is Edgewise Therapeutics, Inc. annual operating income?
  • What is the all time high annual operating profit for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Edgewise Therapeutics, Inc. quarterly operating income?
  • What is the all time high quarterly operating profit for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Edgewise Therapeutics, Inc. TTM operating income?
  • What is the all time high TTM operating profit for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. TTM operating profit year-on-year change?

What is Edgewise Therapeutics, Inc. annual operating income?

The current annual operating profit of EWTX is -$158.83M

What is the all time high annual operating profit for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high annual operating income is -$9.92M

What is Edgewise Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, EWTX annual operating income has changed by -$44.48M (-38.89%)

What is Edgewise Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of EWTX is -$42.61M

What is the all time high quarterly operating profit for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high quarterly operating income is -$3.25M

What is Edgewise Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, EWTX quarterly operating income has changed by -$4.50M (-11.82%)

What is Edgewise Therapeutics, Inc. TTM operating income?

The current TTM operating profit of EWTX is -$174.54M

What is the all time high TTM operating profit for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high TTM operating income is -$3.25M

What is Edgewise Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, EWTX TTM operating income has changed by -$38.37M (-28.17%)
On this page